These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 51463)

  • 21. [Mechanism of rhesus iso-immunisation and of its prevention].
    Ravina JH
    Gynecol Obstet (Paris); 1969; 68(5):461-8. PubMed ID: 4188999
    [No Abstract]   [Full Text] [Related]  

  • 22. Rh-immune globulin in induced abortion: utilization in a high-risk population.
    Judelsohn RG; Berger GS; Wallace RB; Tiller MJ
    Am J Obstet Gynecol; 1972 Dec; 114(8):1031-4. PubMed ID: 4117867
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of leucocyte-antibody formation.
    Tovey GH; Darker CC
    Lancet; 1970 Jun; 1(7661):1396-7. PubMed ID: 4195065
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Prevention of rhesus immunization in Australia.
    Med J Aust; 1975 Aug; 2(7):241. PubMed ID: 808696
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunologic suppression of primary Rh antibody formation.
    Rosenfield RE
    Transfusion; 1968; 8(3):125-6. PubMed ID: 4173359
    [No Abstract]   [Full Text] [Related]  

  • 26. The place for anti-D gamma globulin in abortion.
    Edwards RF
    Aust N Z J Obstet Gynaecol; 1970 May; 10(2):96-8. PubMed ID: 4098622
    [No Abstract]   [Full Text] [Related]  

  • 27. Long Beach (California) experience with Rh immunoglobulin.
    Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
    Transfusion; 1968; 8(3):146-8. PubMed ID: 4174356
    [No Abstract]   [Full Text] [Related]  

  • 28. [Information on Rh-D factor of women who have given birth in our obstetrical department].
    Kogoj-Bakić V; Vujaklija-Stipanović IK
    Bilt Hematol Transfuz; 1975; 3(3):61-4. PubMed ID: 57775
    [No Abstract]   [Full Text] [Related]  

  • 29. Liverpool experience with Rh immunoglobulin.
    Finn R
    Transfusion; 1968; 8(3):148-9. PubMed ID: 4173361
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary and secondary response in relation to the initial detection of anti-Rho (D) in Rh-negative mothers at risk.
    Bishop GJ; Krieger VI
    Med J Aust; 1970 Mar; 1(13):663-8. PubMed ID: 4192292
    [No Abstract]   [Full Text] [Related]  

  • 31. Results of clinical trials of RhoGAM in women.
    Pollack W; Gorman JG; Freda VJ; Ascari WQ; Allen AE; Baker WJ
    Transfusion; 1968; 8(3):151-3. PubMed ID: 4173363
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the anti-D-globulin-prevention of Rh sensitization].
    Haering M; Resch H
    Arch Gynakol; 1967; 204(2):232-3. PubMed ID: 4171916
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the effectiveness of anti Rh gamma globulin].
    García Roel R; Santos Martínez A; Salgado Alcocer N
    Ginecol Obstet Mex; 1974 Jan; 35(207):67-73. PubMed ID: 4133289
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of gamma globulin (anti-Rh IgG) in the prevention of Rh isoimmunization].
    Rosemblit J; Rosales T; de Lima GR; Leonhardt HG; Fonseca A; Martins H
    Matern Infanc (Sao Paulo); 1971; 30(1):41-4. PubMed ID: 5002691
    [No Abstract]   [Full Text] [Related]  

  • 35. The mechanism of action of Rh-immune globulin.
    Clarke CA
    Clin Obstet Gynecol; 1971 Jun; 14(2):611-24. PubMed ID: 4106514
    [No Abstract]   [Full Text] [Related]  

  • 36. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.
    Chilcott J; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C; Tappenden P
    Health Technol Assess; 2003; 7(4):iii-62. PubMed ID: 12633527
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of Rh-sensitization with the use of anti-D gamma-globulin after delivery].
    Keserü TL; Kaiser G; Annus J
    Zentralbl Gynakol; 1971 Jan; 93(1):24-9. PubMed ID: 4102084
    [No Abstract]   [Full Text] [Related]  

  • 38. Maternal-fetal hemorrhage: its incidence and sensitizing effects.
    Jennings ER; Clauss B
    Am J Obstet Gynecol; 1978 Aug; 131(7):725-7. PubMed ID: 99038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A scheme for the detection of patients requiring treatment with anti-D gamma-globulin.
    Hall G; Hazelton JJ
    J Med Lab Technol; 1969 Jan; 26(1):44-8. PubMed ID: 4186154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.